Related Experiment Video
Updated: Jul 9, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Body Mass Index Trajectories Among Patients with Drug-Susceptible and Drug-Resistant Tuberculosis in Northwest
Fasil Wagnew1,2, Kefyalew Addis Alene3,4, Matthew Kelly5
1Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. FasilWagnew.Shiferaw@anu.edu.au.
Introduction:
Understanding predictors of body mass index (BMI) trajectories in patients with drug-susceptible tuberculosis (DS-TB) and drug-resistant TB (DR-TB) is crucial for optimizing treatment strategies. This study examined BMI trajectories and predictors among patients with DS-TB and DR-TB in northwest Ethiopia.
Methods:
A retrospective cohort study was conducted using clinical data from patients attending TB clinics at four public hospitals in Northwest Ethiopia. We modelled BMI trajectories after TB treatment initiation using linear mixed models, with adjustments for potential confounders.
Results:
A total of 988 patients were included in the analysis, comprising 569 with DS-TB and 419 with DR-TB. In the DS-TB cohort, male sex was associated with higher mean BMI (β = 0.39; 95% CI: 0.12-0.65), while baseline underweight status (β = -4.07; 95% CI: -4.33, -3.82) and baseline anaemia (β = -0.27; 95% CI: -0.53, -0.02) were associated with lower mean BMI across follow-up. In the DR-TB cohort, men had a higher mean BMI than women across the follow-up (β = 0.64; 95% CI: 0.16, 1.12). Although participants who were underweight at baseline (β = -3.62; 95% CI -4.06 to -3.18) or anaemic (β = -0.54; 95% CI: -0.98, -0.10) had a lower mean BMI across follow-up, they gained BMI more rapidly over time (time*underweight β = 0.04, 95% CI: 0.01, 0.07; time*anaemia β = 0.05, 95% CI: 0.01, 0.08).
Conclusion:
Early nutritional assessment and tailored nutritional support should be strengthened as part of routine TB care.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis